BIO-key ® International, Inc. (NASDAQ: BKYI), a leading provider of biometric enabled Identity and Access Management SaaS solutions for phoneless, tokenless, passwordless, and phish-resistant ...
Identity-Bound Biometrics (IBB) : Anchoring authentication to the individual—not a device, token, or credential—to ensure true identity verification. Uniquely Passwordless Solutions : Eliminating ...
BIO-key® International, Inc. (NASDAQ: BKYI) shares were little changed Tuesday. The company, claiming to be a leading provider of biometric enabled Identity and Access Management SaaS solutions for ...
Source: Analyst estimates provided by FactSet. Management expectations based on management's guidance, as provided in Q1 2025 earnings report. BIO-key International is known for its Identity-Bound ...
The MarketWatch News Department was not involved in the creation of this content. COPENHAGEN, Denmark and HOLMDEL, N.J., Oct. 27, 2025 (GLOBE NEWSWIRE) -- BIO-key International, Inc. (NASDAQ: BKYI), ...
BIO-key reported a Q2’24 net loss of $1.7M compared to a Q2’23 net loss of $2.6M, primarily due to a $1M hardware reserve in Q2’23. Cash used in operating activities improved 48% to $1.1M in the first ...
BIO-key (BKYI) International announced a strategic partnership with Guinn Partners, a provider of advanced engineering solutions for robotics, drones, and electric propulsion systems. The companies ...
The MarketWatch News Department was not involved in the creation of this content. HOLMDEL, N.J. and RIYADH, Saudi Arabia, Nov. 07, 2025 (GLOBE NEWSWIRE) -- BIO-key International, Inc. (NASDAQ: BKYI), ...
BIO-key is revolutionizing authentication and cybersecurity with biometric-centric, multi-factor identity and access management (IAM) software securing access for over forty million users. BIO-key ...
WALL, N.J., Feb. 03, 2022 (GLOBE NEWSWIRE) --BIO-key International, Inc.(NASDAQ: BKYI), an innovative provider of workforce and customer identity and Access Management (IAM) and Identity-Bound ...
BIO-key (NASDAQ:BKYI) said it had received a continued listing deficiency notice from the Nasdaq because its share price had not met the $1.00 minimum closing bid price requirement for 30 consecutive ...